Maitri Enterprises Limited
Quick Take
- • Trading at 19.7× trailing earnings
- • Strong ROE at 16.0%
- • Leveraged balance sheet (D/E 0.92)
- • No dividend data
- • Operating margin -5.9% · Net margin 2.7%
- • Profit growth — YoY · Beta 0.67
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 5 | -64.29% | -28.57% |
| Operating Profit | -0 | -100.00% | +100.00% |
| Net Profit | -0 | — | +100.00% |
| EPS (₹) | -1.05 | — | +33.54% |
Shareholding Pattern
About the company
From latest AR & concallMaitri Enterprises Limited primarily engages in the trading of pharmaceutical and medical goods in India. The company operates through two segments: Pharmaceutical Goods and Infrastructure and Real Estate. The company also engages in the sale of services by way of a works contract. The company also offers office spaces, residential, retail leasing, and green developments. The company was formerly known as Parth Alluminium Limited and changed its name to Maitri Enterprises Limited in December 2016. Maitri Enterprises Limited was incorporated in 1991 and is based in Ahmedabad, India.
